Novo Integrated Sciences, Inc. NVOS
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $730.0K
- P/E
- 0.0×
Follow NVOS
Growth Flags
show if company had growth for consecutive years
| Aug '24 | May '24 | Feb '24 | Nov '23 | Older periods | |
|---|---|---|---|---|---|
| (82.67%) | (135.33%) | (49.47%) | (63.50%) |
+8 more TTM periods Free account |
|
| (47.76%) | (68.46%) | (33.83%) | (37.23%) | ||
ROIC |
(42.44%) | (71.21%) | (26.28%) | (26.49%) | |
Return on Tangible Assets |
398.81% | 214.21% | (3,945.22%) | (1,163.58%) | |
Average Days of Receivables |
86.54 | 88.98 | 85.58 | 103.08 | |
Free Cash Flow per Share |
(0.28) | (0.26) | (0.28) | (0.25) | |
Free Cash Flow |
(5.12) | (4.80) | (4.95) | (4.12) | |
Capital Expenditures |
(0.05) | (0.05) | — | — | |
Piotroski F-Score |
4.00 | 3.00 | 3.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(30.67%) | (38.73%) | (20.97%) | (15.84%) | |
Accounts Receivable Turnover |
4.69 | 4.77 | 5.28 | 4.58 | |
Accounts Payable Turnover |
2.24 | 2.91 | 3.87 | 2.88 | |
Inventory Turnover |
7.17 | 8.21 | 8.70 | 6.92 | |
Average Days of Payables |
156.39 | 168.75 | 97.38 | 157.52 | |
Days of Inventory on Hand |
48.37 | 48.19 | 42.44 | 58.81 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
105.73% | 115.15% | 109.04% | 113.36% | |
Share Based Compensation of Revenue |
8.99% | 12.40% | 17.05% | 20.26% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.31 | 0.20 | 0.41 | 0.30 | |
Depreciation/Fixed assets |
1.73 | 1.50 | 0.96 | 1.25 | |
Capex/Depreciation |
(0.01) | (0.01) | 0.00 | 0.00 | |
Revenue per Share |
0.74 | 0.72 | 0.77 | 0.78 | |
Operating CF per Share |
(0.28) | (0.25) | (0.28) | (0.25) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(121.61%) | (179.99%) | (88.48%) | (107.02%) |
Columns are period end dates